Tag: Issue #1 2019

INTRODUCTION In a world with an estimated population of 7.6 billion, 2 billion people lack access to medicines that are imperative to their health and […] Read More

Naming pharmaceuticals is a topic that has been thoroughly investigated and buzzed around, and where the world’s expertise agrees on at least one thing. With […] Read More

INTRODUCTION Where to draw the line between the protection of new innovations within the pharmaceutical area, on the one hand, and the generic companies’ right […] Read More